Literature DB >> 16911477

Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology.

Christopher P Gilmore1, Lars Bö, Trudy Owens, James Lowe, Margaret M Esiri, Nikos Evangelou.   

Abstract

The extent and pattern of gray matter (GM) demyelination in the spinal cord in multiple sclerosis (MS) has not been examined in detail. Human autopsy material was obtained from 36 MS cases and 12 controls. Transverse sections were taken from five levels of the spinal cord (upper cervical, lower cervical, upper thoracic, lower thoracic and lumbar levels) and the extent of GM and white matter (WM) demyelination evaluated using proteolipid protein immunohistochemistry (IHC). The proportion of the GM that was demyelinated (33%) was significantly greater than the proportion of demyelinated WM (20%) (P < 0.0001). Similarly, demyelination was more extensive in the GM than in the WM at each of the five cord levels. The extent of GM demyelination was not significantly different between the five cord levels while WM demyelination was greatest at the upper cervical level. Morphologically, the borders of a proportion of the GM plaques show a strict respect for the GM/WM boundary. We demonstrate that extensive demyelination occurs in the GM of the spinal cord in MS. Myelin protein IHC reveals a novel pattern of residual plaque morphology challenging previous work suggesting that MS plaques display a total disregard for anatomical boundaries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911477      PMCID: PMC8095912          DOI: 10.1111/j.1750-3639.2006.00018.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  32 in total

1.  Cortical lesions in multiple sclerosis.

Authors:  D Kidd; F Barkhof; R McConnell; P R Algra; I V Allen; T Revesz
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

2.  Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.

Authors:  G J Nijeholt; M A van Walderveen; J A Castelijns; J H van Waesberghe; C Polman; P Scheltens; P F Rosier; P J Jongen; F Barkhof
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

3.  Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.

Authors:  D K Li; G J Zhao; D W Paty
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

4.  Seizures in multiple sclerosis.

Authors:  D V Sokic; N Stojsavljevic; J Drulovic; I Dujmovic; S Mesaros; M Ercegovac; V Peric; G Dragutinovic; Z Levic
Journal:  Epilepsia       Date:  2001-01       Impact factor: 5.864

5.  Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.

Authors:  M R Kotter; A Setzu; F J Sim; N Van Rooijen; R J Franklin
Journal:  Glia       Date:  2001-09       Impact factor: 7.452

6.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

7.  The cervical cord in multiple sclerosis.

Authors:  D R Oppenheimer
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Mar-Apr       Impact factor: 8.090

8.  Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.

Authors:  G C DeLuca; G C Ebers; M M Esiri
Journal:  Brain       Date:  2004-03-26       Impact factor: 13.501

9.  Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

Authors:  Lars Bø; Christian A Vedeler; Harald I Nyland; Bruce D Trapp; Sverre J Mørk
Journal:  J Neuropathol Exp Neurol       Date:  2003-07       Impact factor: 3.685

10.  The contribution of demyelination to axonal loss in multiple sclerosis.

Authors:  G C DeLuca; K Williams; N Evangelou; G C Ebers; M M Esiri
Journal:  Brain       Date:  2006-04-05       Impact factor: 13.501

View more
  32 in total

1.  Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.

Authors:  M Nakamura; I Miyazawa; K Fujihara; I Nakashima; T Misu; S Watanabe; T Takahashi; Y Itoyama
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

2.  In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

Authors:  Caterina Mainero; T Benner; A Radding; A van der Kouwe; R Jensen; B R Rosen; R P Kinkel
Journal:  Neurology       Date:  2009-07-29       Impact factor: 9.910

Review 3.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 4.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

5.  Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.

Authors:  Dominique Eden; Charley Gros; Atef Badji; Sara M Dupont; Benjamin De Leener; Josefina Maranzano; Ren Zhuoquiong; Yaou Liu; Tobias Granberg; Russell Ouellette; Leszek Stawiarz; Jan Hillert; Jason Talbott; Elise Bannier; Anne Kerbrat; Gilles Edan; Pierre Labauge; Virginie Callot; Jean Pelletier; Bertrand Audoin; Henitsoa Rasoanandrianina; Jean-Christophe Brisset; Paola Valsasina; Maria A Rocca; Massimo Filippi; Rohit Bakshi; Shahamat Tauhid; Ferran Prados; Marios Yiannakas; Hugh Kearney; Olga Ciccarelli; Seth A Smith; Constantina Andrada Treaba; Caterina Mainero; Jennifer Lefeuvre; Daniel S Reich; Govind Nair; Timothy M Shepherd; Erik Charlson; Yasuhiko Tachibana; Masaaki Hori; Kouhei Kamiya; Lydia Chougar; Sridar Narayanan; Julien Cohen-Adad
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

6.  Robust GM/WM segmentation of the spinal cord with iterative non-local statistical fusion.

Authors:  Andrew J Asman; Seth A Smith; Daniel S Reich; Bennett A Landman
Journal:  Med Image Comput Comput Assist Interv       Date:  2013

Review 7.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 8.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 9.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

10.  Groupwise multi-atlas segmentation of the spinal cord's internal structure.

Authors:  Andrew J Asman; Frederick W Bryan; Seth A Smith; Daniel S Reich; Bennett A Landman
Journal:  Med Image Anal       Date:  2014-02-05       Impact factor: 8.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.